GPT and metabolic dysfunction-associated steatotic liver disease: Although not highly sensitive [62], hepatic cytolysis markers (aspartate aminotransferase—AST, and, above all, alanine aminotransferase—ALT) represent the epiphenomenon of the potential hepatic inflammation in NAFLD patients.